Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6

Movement Disorders

Volumn 23, Issue 15, 2008, Pages 2232-2238

  Globas, Christoph ^a   du Montcel, Sophie Tezenas ^b,c   Baliko, Laslo ^d   Boesch, Syliva ^e   Depondt, Chantal ^f   DiDonato, Stefano ^g   Durr, Alexandra ^c   Filla, Alessandro ^h   Klockgether, Thomas ⁱ   Mariotti, Caterina ^g   Melegh, Bela ^j   Rakowicz, Maryla ^k   Ribai, Pascale ^c   Rola, Rafal ^k   Schmitz Hubsch, Tanja ⁱ   Szymanski, Sandra ^l   Timmann, Dagmar ^m   Van de Warrenburg, Bart P ⁿ   Bauer, Peter ^o   Schols, Ludger ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Department of Neurology and Stroke   (Hungary)

^e UNIVERSITY OF INNSBRUCK   (Austria)

^f FREE UNIVERSITY OF BRUSSELS   (Belgium)

^g DEPARTMENT OF NEUROSURGERY   (Italy)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁱ UNIVERSITY OF BONN   (Germany)

^j UNIVERSITY OF PÉCS   (Hungary)

^k INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^l ST JOSEF HOSPITAL   (Germany)

^m UNIVERSITY OF DUISBURG ESSEN   (Germany)

ⁿ RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^o UNIVERSITY OF TÜBINGEN   (Germany)

more..

Author keywords

CAG repeat expansion; Determinants of age at onset; Early symptoms; Spinocerebellar ataxia

Indexed keywords

ADENOSINE; CYTOSINE; GUANOSINE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIPLOPIA; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DYSARTHRIA; DYSGRAPHIA; EPISODIC VERTIGO; FEMALE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION; SPINOCEREBELLAR DEGENERATION TYPE 1; SPINOCEREBELLAR DEGENERATION TYPE 2; SPINOCEREBELLAR DEGENERATION TYPE 3; SPINOCEREBELLAR DEGENERATION TYPE 6; TANDEM REPEAT; WALKING DIFFICULTY;

EID: 61449101789     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22288     Document Type: Article

References (26)

1. Schols L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004;3:291-304.
2. Waters MF, Minassian NA, Stevanin G, et al. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. Nat Genet 2006;38:447-451.
3. Ikeda Y, Dick KA, Weatherspoon MR, et al. Spectrin mutations cause spinocerebellar ataxia type 5. Nat Genet 2006;38:184-190.
4. van de Warrenburg BP, Sinke RJ, Verschuuren-Bemelmans CC, et al. Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis. Neurology 2002;58:702-708.
5. van de Warrenburg BP, Hendriks H, Durr A, et al. Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-French cohort. Ann Neurol 2005;57:505-512.
6. Orr HT, Chung MY, Ban. S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993;4:221-226.
7. Stevanin G, Durr A, Brice A. Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology. Eur J Hum Genet 2000;8:4-18.
8. Schols L, Amoiridis G, Buttner T, Przuntek H, Epplen JT, Riess O. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann Neurol 1997;42:924-932.
9. Lorenzetti D, Bohlega S, Zoghbi HY. The expansion of the CAG repeat in ataxin-2 is a frequent cause of autosomal dominant spinocerebellar ataxia. Neurology 1997;49:1009-1013.
10. Yabe I, Sasaki H, Matsuura T, et al. SCA6 mutation analysis in a large cohort of the Japanese patients with late-onset pure cerebellar ataxia. J Neurol Sci 1998;156:89-95.
11. Pulst SM, Santos N, Wang D, et al. Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset. Brain 2005;128 (Part 10):2297-2303.
12. Durr A, Stevanin G, Cancel G, et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol 1996;39:490-499.
13. Kubis N, Durr A, Gugenheim M, et al. Polyneuropathy in autosomal dominant cerebellar ataxias: phenotype-genotype correlation. Muscle Nerve 1999;22:712-717.
14. Schmitz-Hubsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006;66:1717-1720.
15. Konieczny M, Bauer P, Tomiuk J, et al. CAG repeats in Restless Legs syndrome. Am J Med Genet B Neuropsychiatr Genet 2006;141:173-176.
16. + channel gene CACNL1A4. Cell 1996;87: 543-552.
17. Denier C, Ducros A, Vahedi K, et al. High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2. Neurology 1999;52:1816-1821.
18. Baloh RW, Yue Q, Furman JM, Nelson SF. Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol 1997;41:8-16.
19. Yabe I, Sasaki H, Yamashita I, et al. Initial symptoms and mode of neurological progression in spinocerebellar ataxia type 6 (SCA6). Rinsho Shinkeigaku 1998;38:489-494.
20. Jodice C, Mantuano E, Veneziano L, et al. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet 1997;6:1973-1978.
21. Koh SH, Kim HT, Kim SH, Lee GY, Kim J, Kim MH. Spinocerebellar ataxia type 6 and episodic ataxia type 2 in a Korean family. J Korean Med Sci 2001;16:809-813.
22. Globas C, Bosch S, Zuhlke C, Daum I, Dichgans J, Burk K. The cerebellum and cognition. Intellectual function in spinocerebellar ataxia type 6 (SCA6). J Neurol 2003;250:1482-1487.
23. Burk K, Globas C, Bosch S, et al. Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol 2003;250:207-211.
24. Sarkar S, Perlstein EO, Imarisio S, et al. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 2007;3:331-338.
25. Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and α-synuclein. J Biol Chem 2007; 282:5641-5652.
26. Watase K, Gatchel JR, Sun Y, et al. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model. PLoS Med 2007;4:e182.